I
Innovent Biologics, Inc. (IVBIY)
54.29
0.00 (0.00%)
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
54.29
0.00 (0.00%)
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $0.0 barely cover the upcoming debt maturities $0.0
Total current assets $0.0 are just enough to cover Total current liabilities $0.0, indicating tight liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | N/A | 5.61 | N/A | |
| Quick ratio | N/A | 5.42 | N/A | |
| Debt to Equity | N/A | 0.33 | N/A | |
| Debt to Assets | N/A | 0.05 | N/A | |
| Interest coverage | N/A | 1.88 | N/A | |
| Weighted average score | N/A | |||
| METRIC | TTM |
|---|---|
| Total Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | N/A |
| Net Income | N/A |
| EBITDA | N/A |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | 79.65 | N/A | |
| Operating margin % | N/A | -6.65 | N/A | |
| Net margin % | N/A | -10.76 | N/A | |
| EBITDA margin % | N/A | 15.38 | N/A | |
| Cash flow margin % | N/A | -171.51 | N/A | |
| Weighted average score | N/A | |||
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| ROA | N/A | -9.48 | N/A | |
| ROE | N/A | -12.31 | N/A | |
| ROIC | N/A | -10.43 | N/A | |
| ROCE | N/A | 3.56 | N/A | |
| Weighted average score | N/A | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | N/A |
| Next quarter | N/A | N/A | N/A |
| Current year | N/A | N/A | N/A |
| Next year | N/A | N/A | N/A |
| Weighted average score | N/A | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | N/A | N/A | N/A | N/A | N/A |
| Y/Y | N/A | N/A | N/A | N/A | N/A |
| 3y average | N/A | N/A | N/A | N/A | N/A |
| 5y average | N/A | N/A | N/A | N/A | N/A |
| Weighted average score | N/A | ||||
| NAME | RATIO | INDUSTRY | 5Q TREND | SCORE |
|---|---|---|---|---|
| P/E | N/A | 53.86 | N/A | |
| PEG (5yr expected) | N/A | 2.58 | N/A | |
| P/S | N/A | 11.91 | N/A | |
| P/B | N/A | 5.31 | N/A | |
| Weighted average score | N/A | |||
DCF model data has not been calculated yet.
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Fair Value data has not been calculated yet.
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |